The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil ...
Bankrupt opioid manufacturer Purdue and the Sackler family have agreed to a $7.4 billion settlement to resolve opioid claims by state and municipal governments and individuals.
Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the ...
The Associated Press on MSN14d
Sackler family to pay up to $7 billion cash under Purdue Pharma's new opioid settlement planWASHINGTON — Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle ...
14d
GlobalData on MSNSacklers to pay up to $7bn in Purdue Pharma’s opioid settlement planPurdue Pharma has filed a new bankruptcy plan that details how the funds will be allocated and the proportion paid by its ...
Members of the Sackler family continue to own Purdue Pharma, and to this day, not a single victim has received any compensation, according to a recent status report filed by mediators. And while ...
Purdue Pharma, the pharmaceutical company responsible for OxyContin, has recently filed a new bankruptcy plan outlining a $7.4 billion settlement for their role in the opioid crisis.
Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid ...
WASHINGTON — Purdue Pharma asked a bankruptcy judge late Tuesday ... a deal that would have members of the Sackler family who own the company pay up to $7 billion. The filing is a milestone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results